Page 464 - medicina-integrativa_compress

CAPÍTULO 41 SÍNDROME DEL COLON IRRITABLE 467

19. Silverman DHS, Munakata JA, Ennes H, et al: Regional cerebral diet and partially hydrolysed guar-gum (PHGG) fibre treatment in a
activity in normal and pathologic perception of visceral pain. multicenter randomized open trial. Am J Gastroenterol 96:
Gastroenterology112:64-72, 1997. S321-S322, 2001.
20. Mertz H, Morgan V, Tanner G, et al: Regional cerebral activation in 46. Bijerk CJ, Muris JWM, Knottnerus JA, et al: Systematic review: The
irritable bowel syndrome and control subjects with painful and non- role of different types of fibre in the treatment of irritable bowel
painful rectal distention. Gastroenterology 118:842-848, 2000. syndrome. Aliment Pharmacol Ther 19:245-251, 2004.
21. Drossman DA, McKee DC, Sandler ES, et al: Psychosocial factors in 47. Schrezenemeir J, deVrese M: Prebiotics, probiotics, and synbiotics—
the irritable bowel syndrome: A multivariate study of patients and approaching a definition. Am J Clin Nutr 73:361S-364S, 2001.
nonpatients with irritable bowel syndrome. Gastroenterology 48. Nobaek S, Johansson ML, Molin G, et al: Alteration of intestinal
95:701-708, 1988. microflora is associated with reduction in abdominal bloating and
22. Bearcroft CP, Perrett D, Farthing MJ: Postprandial plasma pain in patients with irritable bowel syndrome. Am J Gastroenterol
5-hydroxytryptamine in diarrhoea predominant irritable bowel 95:1231-1238, 2000.
syndrome: A pilot study. Gut 42:42-46, 1993. 49. O’Mahony L, McCarthy J, Kelly P, et al: Lactobacillus and
23. Barbara G, Stanghellini V, De Giorgio R, et al: Activated mast cells bifidobacterium in irritable bowel syndrome: Symptom responses
in proximity to colonic nerves correlate with abdominal pain in and relationship to cytokine profiles. Gastroenterology 128:541-551,
irritable bowel syndrome. Gastroenterology 126:693-702, 2004. 2005.
24. Wood JD: Enteric neuro-immunology and pathophysiology. 50. Floch M: Use of diet and probiotic therapy in the irritable bowel
Gastroenterology 127:635-657, 2004. syndrome. J Clin Gastroenterol 39:S243-S246, 2005.
25. Neal R, Barker L, Spiller RC: Prognosis in post-infective irritable 51. Rastall RA: Bacteria in the gut: Friends and foes and how to alter the
bowel syndrome: A six year follow-up study. Gut 51:410-413, 2002. balance. J Nutr 134:2022S-2026S, 2004.
26. Tornblom H, Lindberg G, Nyberg B, et al: Full-thickness biopsy of 52. Gibson GR: Dietary modulation of the human gut flora using
the jejunum reveals inflammation and enteric neuropathy in prebiotics. Br J Nutr 80:S209-S212, 1998.
irritable bowel syndrome. Gastroenterology 123:1972-1979, 2002. 53. Hunter JO, Tuffnell Q, Lee AJ: Controlled trial of oligofructose in the
27. Bradesi S, McRoberts JA, Anton PA, et al: Inflammatory bowel management of irritable bowel syndrome. J Nutr 129:1451S-1453S,
disease and irritable bowel syndrome: Separate or unified? Curr 1999.
Opin Gastroenterol 9:336-342, 2003. 54. Pittler MH, Ernst E: Peppermint oil for irritable bowel syndrome:
28. Garcia Rodriguez LA, Ruigomez A, Wallander MA, et al: Detection A critical review and metaanalysis. Am J Gastroenterol 83:
of colorectal tumor and inflammatory bowel disease during follow- 1131-1135, 1998.
up of patients with initial diagnosis of irritable bowel syndrome. 55. Kline RM, Kline JJ, Di Palma J, et al: Enteric-coated, pH-dependent
Scand J Gastroenterol 35:306-311, 2000. peppermint oil capsules for the treatment of irritable bowel
29. Dotan I, Rachmilewitz D: Probiotics in inflammatory bowel disease: syndrome in children. J Pediatr 138:125-128, 2001.
Possible mechanisms of action. Curr Opin Gastroenterol 21:426-430, 56. Spanier JA, Howden CW, Jones MP: A systematic review of
2005. alternative therapies in the irritable bowel syndrome. Ach Intern
30. Spiller R: Probiotics: an ideal anti-inflammatory treatment for IBS. Med 163:265-274, 2003.
Gastroenterology 128:783-785, 2005. 57. Bensoussan A, Talley NJ, Hing M: Treatment of irritable bowel
31. Pimentel M, Chow EJ, Lin HC: Eradication of small intestinal syndrome with Chinese herbal medicine: A randomized controlled
bacterial overgrowth reduces symptoms of irritable bowel syndrome. trial. JAMA 280:1585-1589, 1998.
Am J Gastroenterol 95:3503-3506, 2000. 58. Sallon S, Ben-Arye E, Davidson R, et al: A novel treatment for
32. Chaudhary NA, Truelove SC: The irritable colon syndrome: A study constipation-predominant irritable bowel syndrome using Padma
of the clinical features, predisposing causes, and prognosis in Lax, a Tibetan herbal formula. Digestion 65:161-171, 2002.
130 cases. Q J Med 123:307-322, 1962. 59. Madisch A, Holtman G, Plein K, et al: Treatment of irritable bowel
33. Drossman DA, Talley NJ, Leserman J, et al: Sexual and physical syndrome with herbal preparations: Results of a double-blind,
abuse and gastrointestinal illness. Ann Intern Med 123:782-794, 1995. randomized, placebo-controlled, multi-centre trial. Aliment
34. Mayer EA: The neurobiology of stress and gastrointestinal disease. Pharmacol Ther 19:271-279l, 2004.
Gut 47:861-869, 2000. 60. Shaw G, Srivastava ED, Sadlier M, et al: Stress management for
35. Patacchioli FR, Anagelucci L, Deblerba G, et al: Actual stress, irritable bowel syndrome: A controlled trial. Digestion 50:36-42,
psychopathology and salivary cortisol levels in the irritable bowel 1991.
syndrome. J Endocrinol Invest 24:173-177, 2001. 61. Palsson OS, Turner MJ, Johnson DA, et al: Hypnosis treatment for
36. Bhatia V, Tandon RK: Stress and the gastrointestinal tract. severe irritable bowel syndrome: Investigation of mechanism and
J Gastroenterol Hepatol 20:332-339, 2005. effects on symptoms. Dig Dis Sci 47:2605-2614, 2002.
37. Yakoor J, Jafri W, Jafri N, et al: Irritable bowel syndrome: In search 62. Drossman DA, Toner BB, Whitehead WE, et al: Cognitive-
of an etiology: Role of Blastocystis hominis. Am J Trop Med Hyg behavioral therapy versus education and desipramine versus placebo
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
70:383-385, 2004. for moderate to severe functional bowel disorders. Gastroenterology
38. Ehrenpreis ED: Irritable bowel syndrome: 10% to 20% of older adults 125:19-31, 2003.
have symptoms consistent with diagnosis. Geriatrics 60:25-28, 2005. 63. Bolin TD: Use of oral sodium cromoglycate in persistent diarrhea.
39. Shanahan F: Food allergy: fact, fiction, and fatality. Gastroenterology Gut 21:848-850, 1980.
104:1229-1231, 1993. 64. Stefanini GF, Saggioro A, Alvisi V, et al: Oral cromolyn sodium in
40. Niec AM, Franku B, Talley NJ: Are adverse food reactions linked to comparison with elimination diet in the irritable bowel syndrome,
irritable bowel syndrome? Am J Gastroenterol 93:2184-2190, 1998. diarrheic type: Multicenter study of 428 patients. Scand J
41. Atkinson W, Sheldon TA, Shaath N, et al: Food elimination based Gastroenterol 30:535-541, 1995.
on IgG antibodies in irritable bowel syndrome: A randomised 65. Pimentel M, Park S, Kong Y, et al: Rifaximin, a non-absorbable
controlled trial. Gut 53:1459-1464, 2004. antibiotic, improves the symptoms of irritable bowel syndrome:
42. Gremse DA, Nguyenduc GH, Sacks AI, et al: Irritable bowel A double-blind randomized controlled study. Am J Gastroenterol
syndrome and lactose maldigestion in recurrent abdominal pain in 100:S324, 2005.
childhood. South Med J 92:778-781, 1999. 66. Jackson JL, O’Malley PG, Tomkins G, et al: Treatment of functional
43. Fernandez-Banares F, Esteve-Pardo M, deLeon R, et al: Sugar bowel gastrointestinal disorders with antidepressant medications:
malabsorption in functional bowel disease: Clinical implications. A meta-analysis. Am J Med 108:65-72, 2000.
Am J Gastroenterol 88:2044-2050, 1993. 67. Kuiken SD, Tytgat GNJ, Boeckxstaens GEE: The selective serotonin
44. Floch M: Use of diet and probiotic therapy in the irritable bowel reuptake inhibitor fluoxetine does not change rectal sensitivity and
syndrome. J Clin Gastroenterol 39:S243-S246, 2005. symptoms in patients with irritable bowel syndrome: A double
45. Zilli M, Parisi G, Miani MP, et al: High fibre supplementation in blind, randomized, placebo-controlled study. Clin Gastroenterol
patients with irritable bowel syndrome (IBS): Comparison between Hepatol 1:219-28, 2003.